These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2021431)

  • 21. Reevaluation of the value of prolactin in differentiating malignant from benign pituitary stalk thickening: Letter to the Editor.
    Wang S; Zhou X; Zhu H
    Eur J Endocrinol; 2020 Dec; 183(6):L19-L21. PubMed ID: 33077687
    [No Abstract]   [Full Text] [Related]  

  • 22. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
    Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L
    Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid prolactin: a reflection of abnormal prolactin secretion in patients with pituitary tumors.
    Schroeder LL; Johnson JC; Malarkey WB
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1255-60. PubMed ID: 1002815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody.
    Iwama S; De Remigis A; Callahan MK; Slovin SF; Wolchok JD; Caturegli P
    Sci Transl Med; 2014 Apr; 6(230):230ra45. PubMed ID: 24695685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Forbes-Albright syndrome simulating pituitary apoplexy].
    Kijima Y; Sasaoka T; Kanayama M
    Horumon To Rinsho; 1979 Feb; 27(2):169-74. PubMed ID: 570902
    [No Abstract]   [Full Text] [Related]  

  • 26. The specificity of serum prolactin as a diagnostic indicator of pituitary adenoma.
    Balagura S; Frantz AG; Housepian EM; Carmel PW
    J Neurosurg; 1979 Jul; 51(1):42-6. PubMed ID: 448417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The occurrence of macroscopical pituitary calcifications in prolactinomas.
    Rasmussen C; Larsson SG; Bergh T
    Neuroradiology; 1990; 31(6):507-11. PubMed ID: 2352634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of pituitary adenomas.
    Morrow LB
    Postgrad Med; 1980 Dec; 68(6):155-64. PubMed ID: 6253975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of calcitonin on basal and thyrotropin-releasing hormone-stimulated prolactin secretion in man.
    Isaac R; Merceron R; Caillens G; Raymond JP; Ardaillou R
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1011-5. PubMed ID: 6768762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pituitary disorders.
    Ezrin C
    Bull Los Angeles Neurol Soc; 1977; 42(3-4):81-91. PubMed ID: 227504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis of hyperprolactinemia].
    Schatz H
    Dtsch Med Wochenschr; 1985 Jun; 110(24):962-3. PubMed ID: 4039652
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy of hyperprolactinemia].
    Schatz H
    Dtsch Med Wochenschr; 1985 Jun; 110(24):964-6. PubMed ID: 3996238
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessment of anterior pituitary function in patients with hyperprolactinaemia [proceedings].
    Wilson JD; Sheridan B; Hadden DR
    J Endocrinol; 1979 May; 81(2):117P-118P. PubMed ID: 458302
    [No Abstract]   [Full Text] [Related]  

  • 34. Medical Management of a Prolactinoma in a 15-Year-Old Girl.
    Bowling MS; Zamudio A; Jaffery F
    J Pediatr; 2018 Sep; 200():287-287.e1. PubMed ID: 29685620
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical value of the various methods of ACTH determination].
    Ramschak-Schwarzer S; Lipp R; Passath A; Warnkross H; Stiegler-Heinz C; Dobnig H; Wascher T; Leb G
    Acta Med Austriaca; 1993; 20(3):81-4. PubMed ID: 8396307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of endocrine function in children with hypothalamic-pituitary disorders (author's transl)].
    Stahnke N; Willig RP
    Monatsschr Kinderheilkd; 1981 Feb; 129(2):81-90. PubMed ID: 6112672
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of pituitary function.
    Lindholm J
    Acta Neurol Scand; 1979 Apr; 59(4):161-71. PubMed ID: 452845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of cyproheptadine in decreasing plasma ACTH concentrations in Nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1179-82. PubMed ID: 186479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperprolactinemia--a review of recent clinical advances.
    Kirby RW; Kotchen TA; Rees ED
    Arch Intern Med; 1979 Dec; 139(12):1415-9. PubMed ID: 518224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma LH, FSH and TSH responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases.
    Demura R; Suda T; Wakabayashi I; Ono M; Jibiki K; Odagiri E; Demura H; Shizume K
    Tohoku J Exp Med; 1982 Jul; 137(3):283-7. PubMed ID: 6810504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.